Holen Sie sich die Stockscreener-App
3.65
1.62%
-0.06
Handel nachbörslich:
3.66
0.01
+0.27%
Schlusskurs vom Vortag:
$3.71
Offen:
$3.63
24-Stunden-Volumen:
526.89K
Relative Volume:
0.55
Marktkapitalisierung:
$260.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-192.96M
KGV:
-1.1061
EPS:
-3.3
Netto-Cashflow:
$-167.04M
1W Leistung:
-8.29%
1M Leistung:
+58.70%
6M Leistung:
+231.82%
1J Leistung:
+55.98%
1-Tages-Spanne:
$3.6033
$3.74
1-Wochen-Bereich:
$3.475
$4.04
52-Wochen-Spanne:
$0.783
$4.05
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Firmenname
Ventyx Biosciences Inc
Sektor
Branche
Telefon
(858) 945-2393
Adresse
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Vergleichen Sie VTYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
3.65 | 253.86M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-12 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2023-11-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-03-21 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Buy |
| 2022-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-07 | Eingeleitet | Stifel | Buy |
| 2022-09-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-09 | Eingeleitet | Credit Suisse | Outperform |
| 2022-03-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-15 | Eingeleitet | Jefferies | Buy |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Ventyx Biosciences Inc Aktie (VTYX) Neueste Nachrichten
Real time breakdown of Ventyx Biosciences Inc. stock performanceJuly 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Analyzing drawdowns of Ventyx Biosciences Inc. with statistical toolsMarket Risk Summary & Capital Protection Trade Alerts - newser.com
Will Ventyx Biosciences Inc. see short term momentum2025 Price Momentum & High Accuracy Swing Trade Signals - newser.com
Technical signs of recovery in Ventyx Biosciences Inc.July 2025 Outlook & Daily Chart Pattern Signals - newser.com
Detecting price anomalies in Ventyx Biosciences Inc. with AI2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Is Ventyx Biosciences Inc. stock supported by innovation pipeline2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Will Ventyx Biosciences Inc. stock benefit from infrastructure spending2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Chart based exit strategy for Ventyx Biosciences Inc.GDP Growth & Real-Time Buy Zone Alerts - newser.com
Live market analysis of Ventyx Biosciences Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Relative strength of Ventyx Biosciences Inc. in sector analysisQuarterly Trade Report & Risk Adjusted Buy/Sell Alerts - newser.com
How high can Ventyx Biosciences Inc. stock go2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Is this a good reentry point in Ventyx Biosciences Inc.Market Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Ventyx Biosciences' (VTYX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Ventyx Biosciences, Inc. (VTYX) Is Up 20.81% in One Week: What You Should Know - sharewise.com
Sentiment analysis tools applied to Ventyx Biosciences Inc.Earnings Trend Report & Long-Term Growth Portfolio Plans - newser.com
Is Ventyx Biosciences Inc. stock a top pick in earnings seasonTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Is Ventyx Biosciences Inc. stock a safe buy before earningsEarnings Miss & Verified Trade Idea Suggestions - newser.com
Is Ventyx Biosciences Inc. stock in correction or buying zoneJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
What’s the recovery path for long term holders of Ventyx Biosciences Inc.Market Growth Summary & Weekly Setup with High ROI Potential - newser.com
Signal strength of Ventyx Biosciences Inc. stock in tech scanners2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com
Analyzing recovery setups for Ventyx Biosciences Inc. investorsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Tools to assess Ventyx Biosciences Inc.’s risk profileGap Up & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-10-02 23:37:22 - earlytimes.in
What drives Ventyx Biosciences Inc stock priceDividend Stability Analysis & Free Tremendous Return On Equity - earlytimes.in
Clear Street Initiates Coverage of Ventyx Biosciences (VTYX) with Buy Recommendation - Nasdaq
Ventyx Biosciences Inc Stock Analysis and ForecastStock Buy Signals & Create Your Free Watchlist Instantly - earlytimes.in
Analyst Coverage Initiation: VTYX Receives a 'Buy' Rating | VTYX Stock News - GuruFocus
Ventyx Biosciences stock initiated with Buy rating at Clear Street By Investing.com - Investing.com Canada
Clear Street Initiates Ventyx Biosciences(VTYX.US) With Buy Rating, Announces Target Price $11 - 富途牛牛
Ventyx Biosciences stock initiated with Buy rating at Clear Street - Investing.com India
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ventyx Biosciences Inc-Aktie (VTYX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mohan Raju | CEO AND PRESIDENT |
Mar 28 '25 |
Option Exercise |
0.00 |
11,844 |
0 |
2,303,540 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Mar 28 '25 |
Option Exercise |
0.00 |
4,531 |
0 |
469,113 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 27 '24 |
Sale |
2.36 |
21,119 |
49,841 |
464,582 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):